Contact
Please use this form to send email to PR contact of this press release:
Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes
TO:
Please use this form to send email to PR contact of this press release:
Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes
TO: